Adaptive Biotechnologies (ADPT) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.24 -1.09%
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $37.92 million versus the consensus estimate of $42.96 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
